186 related articles for article (PubMed ID: 25112408)
1. Prognostic role of CD44 expression in osteosarcoma: evidence from six studies.
Liu Y; Wu Y; Gu S; Sun Z; Rui Y; Wang J; Lu Y; Li H; Xu K; Sheng P
Diagn Pathol; 2014 Aug; 9():140. PubMed ID: 25112408
[TBL] [Abstract][Full Text] [Related]
2. Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies.
Liu Y; Ma YH; Sun ZZ; Rui YJ; Yin QD; Song S; Wei XM; Liu J; Liu XG; Hu KJ
Tumour Biol; 2014 Sep; 35(9):8939-43. PubMed ID: 24899264
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.
Nada OH; Ahmed NS; Abou Gabal HH
Diagn Pathol; 2014 Mar; 9():72. PubMed ID: 24667142
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis.
Zhu H; Tang J; Tang M; Cai H
Diagn Pathol; 2013 Nov; 8():183. PubMed ID: 24188461
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.
Wang Z; He M; Xiao Z; Wu H; Wu Y
PLoS One; 2013; 8(12):e82907. PubMed ID: 24358237
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.
Li Z; Liao Q; Wu Y; Liao M; Hao Y; Zhang S; Song S; Li B; Zhang YD
Pathol Oncol Res; 2012 Jul; 18(3):657-61. PubMed ID: 22215309
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
11. Association between PTEN and clinical-pathological features of osteosarcoma.
Zhou J; Xiao X; Wang W; Luo Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31270249
[TBL] [Abstract][Full Text] [Related]
12. Correlation of IGF1R expression with ABCG2 and CD44 expressions in human osteosarcoma.
Kim CK; Oh S; Kim SJ; Leem SH; Heo J; Chung SH
Genes Genomics; 2018 Apr; 40(4):381-388. PubMed ID: 29892839
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 variants in osteosarcoma.
Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-221 from tissue may predict the prognosis of patients with osteosarcoma.
Gong N; Gong M
Medicine (Baltimore); 2018 Jul; 97(29):e11100. PubMed ID: 30024497
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
Zhou J; Liu T; Wang W
Medicine (Baltimore); 2018 Nov; 97(44):e13051. PubMed ID: 30383677
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.
Wu J; Guo A; Li Q; Wang D
Future Oncol; 2017 Sep; 13(21):1883-1891. PubMed ID: 28766969
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma.
Boldrini E; Peres SV; Morini S; de Camargo B
J Pediatr Hematol Oncol; 2010 Aug; 32(6):e213-7. PubMed ID: 20562647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
